Lakeshore Biopharma Co Stock Market Value
| LSBCF Stock | 0.26 0.14 35.00% |
| Symbol | LakeShore |
Can Biotechnology industry sustain growth momentum? Does LakeShore have expansion opportunities? Factors like these will boost the valuation of LakeShore Biopharma. Expected growth trajectory for LakeShore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating LakeShore Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding LakeShore Biopharma requires distinguishing between market price and book value, where the latter reflects LakeShore's accounting equity. The concept of intrinsic value - what LakeShore Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push LakeShore Biopharma's price substantially above or below its fundamental value.
Understanding that LakeShore Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LakeShore Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LakeShore Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
LakeShore Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to LakeShore Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of LakeShore Biopharma.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in LakeShore Biopharma on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding LakeShore Biopharma Co or generate 0.0% return on investment in LakeShore Biopharma over 90 days. LakeShore Biopharma is entity of United States More
LakeShore Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure LakeShore Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess LakeShore Biopharma Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 65.27 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 2.41 |
LakeShore Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for LakeShore Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as LakeShore Biopharma's standard deviation. In reality, there are many statistical measures that can use LakeShore Biopharma historical prices to predict the future LakeShore Biopharma's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (1.89) | |||
| Treynor Ratio | 1.72 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LakeShore Biopharma February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | 1.73 | |||
| Mean Deviation | 2.83 | |||
| Coefficient Of Variation | (739.26) | |||
| Standard Deviation | 8.02 | |||
| Variance | 64.35 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (1.04) | |||
| Total Risk Alpha | (1.89) | |||
| Treynor Ratio | 1.72 | |||
| Maximum Drawdown | 65.27 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 2.41 | |||
| Skewness | (5.40) | |||
| Kurtosis | 31.85 |
LakeShore Biopharma Backtested Returns
LakeShore Biopharma has Sharpe Ratio of -0.18, which conveys that the firm had a -0.18 % return per unit of risk over the last 3 months. LakeShore Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify LakeShore Biopharma's Standard Deviation of 8.02, mean deviation of 2.83, and Risk Adjusted Performance of (0.1) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.64, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning LakeShore Biopharma are expected to decrease at a much lower rate. During the bear market, LakeShore Biopharma is likely to outperform the market. At this point, LakeShore Biopharma has a negative expected return of -1.43%. Please make sure to verify LakeShore Biopharma's maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if LakeShore Biopharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.06 |
Very weak reverse predictability
LakeShore Biopharma Co has very weak reverse predictability. Overlapping area represents the amount of predictability between LakeShore Biopharma time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of LakeShore Biopharma price movement. The serial correlation of -0.06 indicates that barely 6.0% of current LakeShore Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.06 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out LakeShore Biopharma Correlation, LakeShore Biopharma Volatility and LakeShore Biopharma Performance module to complement your research on LakeShore Biopharma. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
LakeShore Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.